The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
KRAS testing of mCRC patients in a community-based oncology setting.
Gebra Cuyun Carter
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Pamela Landsman-Blumberg
Stock Ownership - Merck
Barbara H Johnson
No relevant relationships to disclose
Robert Sedgley
No relevant relationships to disclose
Veena Shankaran
No relevant relationships to disclose